Products for Research Use Only
RegisterLogin

Prasinezumab

CAT: 0804-HY-P99405-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99405-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research[1].
CAS Number
1960462-19-4
Product Name Alternative
PRX 002; RG 7935; RO 7046015
UNSPSC
12352203
Target
α-synuclein
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/prasinezumab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Prasinezumab]
Molecular Weight
(145.26 kDa)
References & Citations
[1]Gennaro Pagano, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA) : Rationale, Design, and Baseline Data. Front Neurol. 2021 Oct 1;12:705407.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
α-synuclein Aggregation

Alternative Products

CatalogName
T76889-01Prasinezumab
592126Prasinezumab (SNCA)
GTR18337886-01Prasinezumab Antibody
MBS1563717-01Research Grade Prasinezumab
E55B0527Prasinezumab (Reference antibody)
ABS-280-1mgPrasinezumab Biosimilar, Research Grade
ICH5786-50mgPrasinezumab Biosimilar - Research Grade
C00405-01Prasinezumab (Anti-Alpha-synuclein)
047967Alpha-synuclein (prasinezumab) discontinued
A138152Prasinezumab Biosimilar (Monoclonal, IgG1)

Popular Products